Form 40-17F1 Amplify ETF Trust Filed by: Amplify ETF Trust

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-17f-1

 

Certificate of Accounting of Securities and Similar
Investments of a Management Investment Company
in the Custody of Members of
National Securities Exchanges

 

Pursuant to Rule 17f-1 [17 CFR 270.17f-1]

 

1. Investment Company Act File Number: 811-23108					Date examination completed: 10/31/2022
2. State identification Number:
	AL	AK	AZ	AR	CA	CO
	CT	DE	DC	FL	GA	HI
	ID	IL	IN	IA	KS	KY
	LA	ME	MD	MA	MI	MN
	MS	MO	MT	NE	NV	NH
	NJ	NM	NY	NC	ND	OH
	OK	OR	PA	RI	SC	SD
	TN	TX	UT	VT	VA	WA
	WV	WI	WY	PUERTO RICO
	Other (specify):
3. Exact name of investment company as specified in registration statement: Amplify Seymour Cannabis ETF
4. Address of principal executive office (number, street, city, state, zip code): 310 South Hale Street, Wheaton, Illinois 60187

 

INSTRUCTIONS

 

This Form must be completed by investment companies that place or maintain securities or similar investments in the custody of a company that is a member of a national securities exchange.

 

Investment Company

 

1.

All items must be completed by the investment company.

 

2.

Give this Form to the independent public accountant who, in compliance with Rule 17f-1 under the Act and applicable state law, examines securities and similar investments in the custody of a company that is a member of a national securities exchange.

 

Accountant

 

3.

Submit this Form to the Securities and Exchange Commission and appropriate state securities administrators when filing the certificate of accounting required by Rule 17f-1 under the Act and applicable state law. File the original and one copy with the Securities and Exchange Commission’s principal office in Washington, D.C., one copy with the regional office for the region in which the investment company’s principal business operations are conducted, and one copy with the appropriate state administrator(s), if applicable.

 

THIS FORM MUST BE GIVEN TO YOUR INDEPENDENT PUBLIC ACCOUNTANT

 

SEC 2205 (11-03)

  

 

 

SEC’s Collection of Information

 

An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Filing of Form N-17f-1 is mandatory for an investment company that maintains securities or similar investments in the custody of a member of a National Securities Exchange. Rule 17f-1 under section 17(f) of the Investment Company Act of 1940 requires the investment company to retain an independent public accountant to verify the company’s securities and similar investments by actual examination three times during each fiscal year. The accountant must prepare a certificate stating that the examination has occurred and describing the examination, and must transmit the certificate to the Commission with Form N-17f-1 as a cover sheet. The Commission uses the Form to ensure that the certificate is properly attributed to the investment company. The Commission estimates that the burden of completing Form N-17f-1 is approximately 0.16 hours per filing. Any member of the public may direct to the Commission any comments concerning the accuracy of the burden estimate of this Form, and any suggestions for reducing the burden of the Form. This collection of information has been reviewed by the Office of Management and Budget in accordance with the clearance requirements of 44

 

U.S.C. § 3507. Responses to this collection of information will not be kept confidential.

 

 

Management Statement Regarding Compliance With Certain Provisions of the Investment Company Act of 1940

 

January 19, 2023

 

We, as members of management of Amplify Seymour Cannabis ETF (the Fund), are responsible for complying with the requirements of subsections (b)(1) and (b)(6) of Rule 17f-1, "Custody of Securities with Members of National Securities Exchanges" of the Investment Company Act of 1940. We are also responsible for establishing and maintaining effective internal controls over compliance with those requirements. We have performed an evaluation of the Fund's compliance with the requirements of subsections (b)(1) and (b)(6) of Rule 17f-1 as of October 31, 2022, and from August 15, 2022 through October 31, 2022.

 

Based on this evaluation, we assert that the Fund was in compliance with the requirements of subsections (b)(1) and (b)(6) of Rule 17f-1 of the Investment Company Act of 1940 as of October 31, 2022, and from August 15, 2022 through October 31, 2022, with respect to securities reflected in the investment account of the Fund.

 

Amplify Seymour Cannabis ETF
By:
/s/ Christian Magoon
Christian Magoon, President & CEO
/s/ Bradley H. Bailey
Bradley H. Bailey, Chief Financial Officer

 

 

 

 

 

Report of Independent Public Accountant

 

To the Board of Trustees of

Amplify Seymour Cannabis ETF

 

We have examined management of Amplify Seymour Cannabis ETF's assertion, included in the accompanying Management Statement Regarding Compliance With Certain Provisions of the Investment Company Act of 1940, that Amplify Seymour Cannabis ETF (the “Fund”), a series of Amplify ETF Trust, complied with the requirements of subsections (b)(1) and (b)(6) of Rule 17f-1 under the Investment Company Act of 1940 (the “Act”) (the “specified requirements”) as of October 31, 2022. Amplify Seymour Cannabis ETF's management is responsible for its assertion. Our responsibility is to express an opinion on management's assertion about the Fund’s compliance with the specified requirements based on our examination.

 

Our examination was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants. Those standards require that we plan and perform the examination to obtain reasonable assurance about whether management's assertion about compliance with the specified requirements is fairly stated, in all material respects. An examination involves performing procedures to obtain evidence about whether management's assertion is fairly stated in all material respects. The nature, timing, and extent of the procedures selected depend on our judgment, including an assessment of the risks of material misstatement of management's assertion, whether due to fraud or error. We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.

 

We are required to be independent and to meet our other ethical responsibilities in accordance with relevant ethical requirements relating to the engagement.

 

Included among our procedures were the following tests performed as of October 31, 2022, and with respect to agreement of security purchases and sales, for the period from August 15, 2022 (the date of our last examination) through October 31, 2022:

 

·

Confirmation of all securities held by institutions in book entry form with Cowen and Company, LLC (“Cowen”).

·

Confirmation of all securities hypothecated, pledged, placed in escrow, or out for transfer with brokers, pledgees, or transfer agents.

·

Reconciliation of all such securities between the books and records of the Fund and Cowen.

·

Agreement of six security purchases and one security sale since the date of our last examination from the books and records of the Fund to broker confirmations.

 

We believe that our examination provides a reasonable basis for our opinion. Our examination does not provide a legal determination on the Fund’s compliance with specified requirements.

 

In our opinion, management's assertion that Amplify Seymour Cannabis ETF complied with the requirements of subsections (b)(1) and (b)(6) of Rule 17f-1 of the Investment Company Act of 1940 as of October 31, 2022, with respect to securities reflected in the investment account of the Fund is fairly stated, in all material respects.

 

This report is intended solely for the information and use of management and the Board of Trustees of Amplify ETF Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

/s/ Cohen & Company, LTD.

COHEN & COMPANY, LTD.

Milwaukee, Wisconsin

January 19, 2023

 

 

  

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wolters Kluwer’s MediRegs triumphs in 2024 BIG Innovation Awards
• Company announcement no 6/2024 - Finance Calendar update
• Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans